Literature DB >> 34156506

Trigone as a diagnostic and therapeutic target for bladder-centric interstitial cystitis/bladder pain syndrome.

Amy D Dobberfuhl1, Stefanie van Uem2, Eboo Versi3.   

Abstract

The pathophysiology of interstitial cystitis/bladder pain syndrome (IC/BPS) may be bladder-centric, with afferent nerve hyperexcitability and/or due to neural central sensitization. In bladder-centric disease, the trigone's unmyelinated nociceptive C-fibers are thought to be upregulated, suggesting this as a potential target for diagnostic modalities and for treatment with local anesthetics and chemodenervation. We propose that the transvaginal trigone treatment (T3) route of administration of such treatments should be considered in women with IC/BPS, as this approach is easier and less invasive than cystoscopy. For T3, or other bladder-centric treatments to be successful, patient selection should attempt to exclude patients with predominantly neural central sensitization.
© 2021. The International Urogynecological Association.

Entities:  

Keywords:  Afferent pathways; Female; Interstitial cystitis; Local anesthetics; Type A botulinum toxins; Urinary bladder

Mesh:

Substances:

Year:  2021        PMID: 34156506     DOI: 10.1007/s00192-021-04878-9

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  21 in total

1.  Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States.

Authors:  Sandra H Berry; Marc N Elliott; Marika Suttorp; Laura M Bogart; Michael A Stoto; Paul Eggers; Leroy Nyberg; J Quentin Clemens
Journal:  J Urol       Date:  2011-06-16       Impact factor: 7.450

Review 2.  Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment.

Authors:  Philip M Hanno; Deborah Erickson; Robert Moldwin; Martha M Faraday
Journal:  J Urol       Date:  2015-01-23       Impact factor: 7.450

Review 3.  Neuroselective measure of the current perception threshold of A-delta and C-fiber afferents in the lower urinary tract.

Authors:  Atsuko Fujihara; Osamu Ukimura; Tsuyoshi Iwata; Tsuneharu Miki
Journal:  Int J Urol       Date:  2011-03-28       Impact factor: 3.369

4.  Antimuscarinic effects on current perception threshold: a prospective placebo control study.

Authors:  Gopalan Vijaya; G Alessandro Digesu; Alexandros Derpapas; Caroline Hendricken; Ruwan Fernando; Vik Khullar
Journal:  Neurourol Urodyn       Date:  2011-10-28       Impact factor: 2.696

5.  Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial.

Authors:  Rui Almeida Pinto; Daniel Costa; Afonso Morgado; Pedro Pereira; Ana Charrua; João Silva; Francisco Cruz
Journal:  J Urol       Date:  2017-10-13       Impact factor: 7.450

6.  Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Stephen J Walker; João Zambon; Karl-Erik Andersson; Carl D Langefeld; Catherine A Matthews; Gopal Badlani; Heather Bowman; Robert J Evans
Journal:  J Urol       Date:  2017-02-12       Impact factor: 7.450

7.  Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.

Authors:  Hann-Chorng Kuo; Yuan-Hong Jiang; Yao-Chou Tsai; Yuh-Chen Kuo
Journal:  Neurourol Urodyn       Date:  2015-04-24       Impact factor: 2.696

Review 8.  Beyond a Simple Anesthetic Effect: Lidocaine in the Diagnosis and Treatment of Interstitial Cystitis/bladder Pain Syndrome.

Authors:  Richard A Henry; Alvaro Morales; Catherine M Cahill
Journal:  Urology       Date:  2015-05       Impact factor: 2.649

Review 9.  Neural upregulation in interstitial cystitis.

Authors:  Omar Nazif; Joel M H Teichman; G F Gebhart
Journal:  Urology       Date:  2007-04       Impact factor: 2.649

Review 10.  The neural control of micturition.

Authors:  Clare J Fowler; Derek Griffiths; William C de Groat
Journal:  Nat Rev Neurosci       Date:  2008-06       Impact factor: 34.870

View more
  1 in total

Review 1.  Clinical Application of Botulinum Neurotoxin in Lower-Urinary-Tract Diseases and Dysfunctions: Where Are We Now and What More Can We Do?

Authors:  Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2022-07-18       Impact factor: 5.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.